Kamat - Figure 9
American Urological Association
References
Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer; unabridged version: American Urological Association (AUA)/Society of Urologic Oncology (SUO) guideline. Linthicum, MD:American Urological Association; 2016 https://www.auanet.org/documents/education/clinical-guidance/Non-Muscle-Invasive-Bladder-Cancer.pdf Accessed June 17, 2017.
Babjuk M, Böhle A, Burger M, et al.EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol. 2017;71:447–61 http://dx.doi.org/10.1016/j.eururo.2016.05.041
Spiess PR et al; NCCN Guidelines Version 5.2017 Panel Members Bladder Cancer. NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer Version 5.2017. Fort Washington, PA: National Comprehensive Cancer Network; 2017 https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf
National Institute for Health and Care Excellence (NICE). Bladder Cancer: Diagnosis and management. NICE guideline.London,UK: NICE; 2015 https://www.nice.org.uk/guidance/ng2/chapter/1-recommendations
